The diagnosis of NASH provided to us by the University of Pittsburgh was further corroborated by a significant upregulation of interleukin-6 mRNA expression in liver NASH samples (Supplementary Fig. 2a). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.